Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

AbstractAimsOwing to strong linkage disequilibrium between markers, pinpointing disease associations within genetic regions is difficult in European ancestral populations, most notably the very strong association of the HLA‐DRB1*03‐DQA1*05:01‐DQB1*02:01 haplotype with Type 1 diabetes risk, which is assumed to be because of a combination of HLA‐DRB1 and HLA‐DQB1. In contrast, populations of African ancestry have greater haplotype diversity, offering the possibility of narrowing down regions and strengthening support for a particular gene in a region being causal. We aimed to study the human leukocyte antigen (HLA) region in African American Type 1 diabetes.MethodsTwo hundred and twenty‐seven African American patients with Type 1 diabetes and 471 African American control subjects were tested for association at the HLA class II genes, HLA‐DRB1, HLA‐DQA1, HLA‐DQB1 and 5147 single nucleotide polymorphisms across the major histocompatibility complex region using logistic regression models. Population admixture was accounted for with principal components analysis.ResultsSingle nucleotide polymorphism marker associations were explained by the HLA associations, with the major peak over the class II loci. The HLA association overall was extremely strong, as expected for Type 1 diabetes, even in African Americans in whom diabetes diagnosis is heterogeneous. In addition, there were unique features: the HLA‐DRB1*03 haplotype was split into HLA‐DRB1*03:01, which confers greatest susceptibility in these samples (odds ratio 3.17, 95% CI 1.72–5.83) and HLA‐DRB1*03:02, an allele rarely observed in Europeans, which confers the greatest protection in these African American samples (odds ratio 0.22, 95% CI 0.09–0.55).ConclusionsThe unique diversity of the African HLA region we have uncovered supports a specific and major role for HLA‐DRB1 in HLA‐DRB1*03 haplotype‐associated Type 1 diabetes risk.

Original publication

DOI

10.1111/dme.12148

Type

Journal article

Journal

Diabetic Medicine

Publisher

Wiley

Publication Date

06/2013

Volume

30

Pages

710 - 716